Skip to main content

Proceeding contribution from Jack Straw (Labour) in the House of Commons on Thursday, 1 February 2007. It occurred during Business statement on Business of the House.


Business of the House

Of course I understand the hon. Lady’s concern. Health questions will take place next Tuesday, and she has not missed the deadline, so I suggest that she table a question. There is, I think, cross-party agreement that the NICE arrangement for independent assessment of new drug treatments is sensible, and better than the alternative. Whoever is in government, there are critical and difficult questions about whether to approve drugs and make them generally available. That is the reality, but I am aware that some individuals at the margin are disadvantaged and are in a difficult position.


Secondary information

Type
Proceeding contribution
Reference
456 c369 
Session
2006-07
Chamber / Committee
House of Commons chamber
Subjects
NHS Medical treatments Prescription drugs National Institute for Health and Care Excellence
Link
View this Proceeding contribution on www.publications.parliament.uk